Nasdaq compliance removes near-term delisting risk but does not change INM's weak fundamental outlook — the stock still trades near the $1 threshold with minimal analyst support. Monitor upcoming quarterly results for any revenue or pipeline catalyst that could sustain the bid price above $1.
Price Chart
Executive Summary
InMed Pharmaceuticals has regained compliance with Nasdaq's minimum bid price requirement, closing a delisting notice received on March 27, 2026. The company demonstrated a closing bid price at or above $1.00 for 10 consecutive business days through June 2, 2026. This is a procedural compliance update — it removes an immediate delisting overhang but does not change the company's operational or financial trajectory.
Key Facts
- InMed received a Nasdaq deficiency notice on March 27, 2026 for non-compliance with the $1.00 bid price rule (Rule 5550(a)(2))
- Nasdaq confirmed compliance on June 3, 2026, based on 10 consecutive business days (May 19–June 2, 2026) with closing bid at or above $1.00
- The matter is now closed with no further action required by Nasdaq
- Company has a market cap of ~$4M and analyst consensus is 0% bullish (3 Hold, 4 Sell, 1 Strong Sell)
Financial Impact
No direct financial impact; removal of delisting risk removes a potential liquidity and capital-access overhang
Risk Factors
- Stock could fall back below $1.00, triggering a new deficiency process
- No revenue or operational catalyst announced — continued listing remains dependent on share price stability
- Low market cap and bearish analyst consensus suggest limited institutional support
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001062993-26-003132 |
| Exhibit: exhibit99-1.htm | 0001062993-26-003132 |
| Document: 0001062993-26-003132-index-headers.html | 0001062993-26-003132 |
| Document: 0001062993-26-003132-index.html | 0001062993-26-003132 |
| Document: 0001062993-26-003132.txt | 0001062993-26-003132 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 9, 2026 22d ago | 425 | $1.31 $1.39 | ▲ +6.11% | ▲ +6.61% | $1.33 (+1.53%) |
Jul 10, 2026 12w ago | 8-K | $1.57 $1.52 | ▲ +3.18% | ▲ +2.40% | $1.33 (+15.29%) |
Jul 2, 2026 13w ago | S-4 | $1.56 $1.66 | ▼ −6.41% | ▼ −5.48% | $1.33 (+14.74%) |
Jun 11, 2026 16w ago | Insider Cluster | $1.58 $1.49 | ▼ −5.70% | ▼ −6.13% | $1.33 (−15.82%) |
Jun 10, 2026 16w ago | 8-K | $1.51 $1.48 | ▼ −1.99% | ▼ −5.42% | $1.33 (−11.92%) |
May 19, 2026 19w ago | 425 | $1.60 $1.69 | ▲ +5.63% | ▲ +3.38% | $1.33 (−16.87%) |
May 19, 2026 19w ago | 8-K | $1.60 $1.69 | ▲ +5.63% | ▲ +3.38% | $1.33 (−16.87%) |
May 19, 2026 19w ago | 8-K | $1.60 $1.66 | ▼ −3.75% | ▼ −1.45% | $1.33 (+16.87%) |
Apr 27, 2026 22w ago | 8-K | $0.7010 $0.7480 | ▼ −6.70% | ▼ −5.01% | $1.33 (−89.73%) |
Apr 3, 2026 26w ago | 8-K | $0.6950 $0.7130 | ▲ +2.59% | ▼ −1.54% | $1.33 (+91.37%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access